KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Change in Receivables: 2009-2024

Historic Change in Receivables for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $7.7 million.

  • Pacira BioSciences' Change in Receivables rose 121.73% to $897,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 294.86%. This contributed to the annual value of $7.7 million for FY2024, which is 8.23% up from last year.
  • According to the latest figures from FY2024, Pacira BioSciences' Change in Receivables is $7.7 million, which was up 8.23% from $7.2 million recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Change in Receivables registered a high of $10.4 million during FY2021, and its lowest value of $2.1 million during FY2022.
  • For the 3-year period, Pacira BioSciences' Change in Receivables averaged around $5.7 million, with its median value being $7.2 million (2023).
  • Its Change in Receivables has fluctuated over the past 5 years, first slumped by 80.07% in 2022, then surged by 244.35% in 2023.
  • Pacira BioSciences' Change in Receivables (Yearly) stood at $5.5 million in 2020, then spiked by 89.16% to $10.4 million in 2021, then plummeted by 80.07% to $2.1 million in 2022, then soared by 244.35% to $7.2 million in 2023, then climbed by 8.23% to $7.7 million in 2024.